Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

BRANCATELLI, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.362
EU - Europa 6.646
AS - Asia 4.898
SA - Sud America 789
AF - Africa 182
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 6
Totale 22.896
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.211
SG - Singapore 1.733
RU - Federazione Russa 1.584
IT - Italia 1.566
CN - Cina 1.333
DE - Germania 781
UA - Ucraina 618
BR - Brasile 615
FI - Finlandia 572
HK - Hong Kong 563
VN - Vietnam 434
PL - Polonia 329
FR - Francia 279
GB - Regno Unito 256
IE - Irlanda 238
JP - Giappone 201
SE - Svezia 134
KR - Corea 119
IN - India 104
BD - Bangladesh 82
CA - Canada 68
NL - Olanda 58
AR - Argentina 57
CI - Costa d'Avorio 56
TR - Turchia 49
RO - Romania 48
MX - Messico 47
BE - Belgio 42
IQ - Iraq 38
ES - Italia 33
ZA - Sudafrica 31
UZ - Uzbekistan 30
AT - Austria 27
EC - Ecuador 24
ID - Indonesia 23
CO - Colombia 22
MA - Marocco 21
PK - Pakistan 20
VE - Venezuela 20
SA - Arabia Saudita 19
IR - Iran 18
PH - Filippine 18
CL - Cile 16
DZ - Algeria 16
AE - Emirati Arabi Uniti 15
KE - Kenya 15
CH - Svizzera 14
MY - Malesia 14
PY - Paraguay 12
AU - Australia 11
JO - Giordania 11
EG - Egitto 10
JM - Giamaica 10
KZ - Kazakistan 9
UY - Uruguay 9
AZ - Azerbaigian 8
BG - Bulgaria 8
CZ - Repubblica Ceca 8
IL - Israele 8
BY - Bielorussia 7
LT - Lituania 7
PE - Perù 7
RS - Serbia 7
TN - Tunisia 7
BO - Bolivia 6
EU - Europa 6
HN - Honduras 6
NP - Nepal 6
OM - Oman 6
PS - Palestinian Territory 6
AL - Albania 5
AO - Angola 5
GE - Georgia 5
SN - Senegal 5
SY - Repubblica araba siriana 5
DK - Danimarca 4
DO - Repubblica Dominicana 4
GR - Grecia 4
TH - Thailandia 4
BH - Bahrain 3
EE - Estonia 3
HR - Croazia 3
HU - Ungheria 3
KG - Kirghizistan 3
LB - Libano 3
NG - Nigeria 3
PA - Panama 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BB - Barbados 2
BW - Botswana 2
CR - Costa Rica 2
CY - Cipro 2
MK - Macedonia 2
ML - Mali 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
TG - Togo 2
TW - Taiwan 2
Totale 22.879
Salva come PNG Salva come JPEG
Città #
Ashburn 1.258
Singapore 1.138
Fairfield 1.087
Chandler 632
San Jose 617
Woodbridge 611
Hong Kong 537
Wilmington 464
Houston 459
Seattle 392
Ann Arbor 391
Cambridge 368
Jacksonville 342
Zgierz 299
Moscow 286
Dublin 238
Palermo 228
Beijing 227
Tokyo 197
Medford 195
Santa Clara 184
Frankfurt am Main 169
Los Angeles 148
Nanjing 146
Council Bluffs 143
Ho Chi Minh City 140
Lauterbourg 139
New York 133
Princeton 132
Helsinki 115
Des Moines 110
Hanoi 104
Dallas 102
Munich 100
Altamura 99
Hefei 96
Boardman 88
Milan 84
Tulsa 84
Rome 79
Lawrence 75
São Paulo 70
Dearborn 69
Buffalo 65
San Diego 57
Abidjan 56
The Dalles 56
Chicago 49
Jinan 47
Orem 42
Changsha 41
Nanchang 41
Shenyang 40
Tianjin 40
Ludwigshafen am Rhein 38
Brussels 35
London 35
Jiaxing 30
Nuremberg 29
Columbus 28
Hebei 28
Phoenix 28
Venice 28
Amsterdam 26
Atlanta 24
Montreal 24
Tashkent 24
Brooklyn 23
Paris 23
Verona 23
Chennai 22
Seongnam 22
Da Nang 21
Denver 21
Haiphong 21
City of London 20
Saint Petersburg 20
Zhengzhou 20
Krefeld 18
Ningbo 18
Johannesburg 17
Redwood City 17
Shanghai 17
Toronto 17
Warsaw 17
Biên Hòa 16
Falls Church 16
Boston 15
Florence 15
San Paolo di Civitate 15
Lanzhou 14
Rio de Janeiro 14
San Francisco 14
Stockholm 14
Ottawa 13
Tehran 13
Baghdad 12
Dhaka 12
Hangzhou 12
Nairobi 12
Totale 14.050
Salva come PNG Salva come JPEG
Nome #
PRESENTAZIONE ECOGRAFICA DELL’EPATOCARCINOMA: ESPERIENZA DI UN SINGOLO CENTRO NELL’ARCO DI TRE DECENNI 401
Whipple's pancreaticoduodenectomy: Surgical technique and perioperative clinical outcomes in a single center 321
The presence of white matter lesions is associated with the fibrosis severity of nonalcoholic fatty liver disease 293
Survival of Patients with Hepatocellular Carcinoma (HCC) Treated by Percutaneous Radio-Frequency Ablation (RFA) Is Affected by Complete Radiological Response 274
ASPETTI TC ED RM NELLA RETRAZIONE CAPSULARE EPATICA 273
Hepatocellular carcinoma: Comparison of two different periods at the same center 273
Surveillance program for diagnosis of hcc in liver cirrhosis: Role of ultrasound echo patterns 261
What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment 253
The cheating liver: imaging of focal steatosis and fatty sparing 252
Common and uncommon pitfalls in pancreatic imaging: it is not always cancer 251
Assessment of treatment response in hepatocellular carcinoma: a review of literature 238
Peliosis hepatis: spectrum of imaging findings 236
Treatment of hepatocellular carcinoma: present and future. 234
Predicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisation 233
Focal nodular hyperplasia-like lesions in patients with cavernous transformation of the portal vein: prevalence, MR findings and natural history 233
Focal lesions in cirrhotic liver: what else beyond hepatocellular carcinoma? 232
The Changing Epidemiology of Hepatocellular Carcinoma :  Experience of a Single Center 222
Imaging findings of liver resection using a bipolar radiofrequency electrosurgical device-Initial observations. 221
Focal liver lesions in patients with cavernous transformation of the portal vein: diagnosis and MR features. 219
Aspetti con TC ed RM delle cisti peribiliari 219
ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents 215
Le calcificazioni pancreatiche sono specifiche nella diagnosi di pancreatite cronica? Studio con TC multidetettore. 211
Magnetic resonance imaging of the cirrhotic liver in the era of gadoxetic acid 207
CHRONIC ATRIAL FIBRILLATION IN PRESENCE OF AORTIC STENOSIS IN A PATIENT WITH POLYSPLENIA SYNDROME 205
CT and MR imaging of chemotherapy-induced hepatopathy 205
Are pancreatic calcifications specific for the diagnosis of chronic pancreatitis? A multidetector-row CT analysis. 203
Ultrasonic evaluation with second harmonic imaging and SonoVue in the assessment of cerebral perfusion in diabetic patients: a case-control study 201
Natural history of untreatable hepatocellular carcinoma: A retrospective cohort study 199
Focal nodular hyperplasia: a weight-based, intraindividual comparison of gadobenate dimeglumine and gadoxetate disodium-enhanced MRI 199
Comparison of the Enhancement Pattern of Hepatic Hemangioma on Magnetic Resonance Imaging Performed With Gd-EOB-DTPA Versus Gd-BOPTA 195
Budd-Chiari Syndrome: spectrum of imaging findings. 194
Imaging of Hepatic Focal Nodular Hyperplasia: Pictorial Review and Diagnostic Strategy 194
Osteonecrosis detected by whole body magnetic resonance in patients with Hodgkin Lymphoma treated by BEACOPP 193
Acute extrahepatic infectious or inflammatory diseases are a cause of transient mosaic pattern on CT and MR imaging related to sinusoidal dilatation of the liver 191
Enhancement pattern of small hepatocellular carcinoma (HCC) at contrast-enhanced US (CEUS), MDCT, and MRI: intermodality agreement and comparison of diagnostic sensitivity between 2005 and 2010 American Association for the Study of Liver Diseases (AASLD) guidelines 189
Benign and malignant mimickers of infiltrative hepatocellular carcinoma: tips and tricks for differential diagnosis on CT and MRI 189
A case of infective colitis due to Yersinia enterocolitica complicated by microliver abscesses mimicking multiple liver occult metastases: a case report 189
Education and Imaging. Hepatobiliary and pancreatic: Portal hypertensive biliopathy presenting as acute cholangitis. 184
Budd-Chiari syndrome: spectrum of imaging findings. 183
Utrastructural biologic effects of sonography with pulse inversion and microbubble contrast in rabbit liver 183
Computed tomographic imaging of hepatocellular carcinoma. 180
Complications of hepatic echinococcosis: multimodality imaging approach 180
Focal liver lesions hyperintense on T1-weighted magnetic resonance images. 179
Cirrhosis: CT and MR imaging evaluation. 178
Avoiding Pitfalls in the Interpretation of Gadoxetic Acid–Enhanced Magnetic Resonance Imaging 177
The presence of White Matter Lesions is not associated with Non-alcoholic Fatty Liver Disease but with its histological severity 176
Abdominal splenosis and its differential diagnoses: What the radiologist needs to know 175
Hepatobiliary phase in cirrhotic patients with different Model for End-stage Liver Disease score: comparison of the performance of gadoxetic acid to gadobenate dimeglumine 175
Cerebral Vessels. 174
Imaging appearance of treated hepatocellular carcinoma. 174
Are radiological endpoints surrogate outcomes of overall survival in hepatocellular carcinoma treated with transarterial chemoembolization? 173
Hepatocellular carcinoma enhancement on contrast-enhanced CT and MR imaging: response assessment after treatment with sorafenib: preliminary results. 173
Fibropolycystic liver disease: CT and MR imaging findings. 172
Gadoxetate disodium-enhanced magnetic resonance cholangiography for the noninvasive detection of an active bile duct leak after laparoscopic cholecystectomy. 172
Uncommon imaging evolutions of focal liver lesions in cirrhosis 172
Aspetti delle lesioni cistiche epatiche con TC ed RM obiettivi 169
Science to practice: Should biopsy be performed in potential liver donors when unenhanced CT shows an unacceptable degree of steatosis for transplantation? 167
Cavernous haemangioma associated with other hepatic masses at CT and MRI 167
Gadoxetic acid-enhanced MRI of transient hepatic enhancement differences: Another cause of hypointense observation on hepatobiliary phase 167
Benign and malignant focal liver lesions displaying rim arterial phase hyperenhancement on CT and MRI 165
Ernie della parete addominale ed ernie interne: ruolo della tcmd nella gestione clinica del paziente. 163
Spectrum of liver lesions hyperintense on hepatobiliary phase: an approach by clinical setting 163
Percutaneous radiofrequency ablation for hepatocellular carcinoma before liver transplantation: a prospective study with histopathologic comparison. 162
Focal confluent fibrosis: findings at CT and MRI in the cirrhotic liver 161
Focal confluent fibrosis in cirrhotic liver: natural history studied with serial CT. 160
Arterially enhancing liver lesion: significance of sustained enhancement on delayed phase with MR imaging 157
causes of false positive interpretation for hepatocellular carcinoma in cirrhosis 154
VALUTAZIONE DELLA PERFUSIONE CEREBRALE CON ECOGRAFIA TRANSCRANICA (TCCD) E MEZZO DI CONTRASTO (MDC) IN PAZIENTI DIABETICI: STUDIO CASO-CONTROLLO 154
Moderne Diagnostik zystischer Leberläsionen und Hämangiome 154
Benign and malignant conditions in hepatic capsular retraction 151
Utility of CT in the diagnosis of pancreatic fistula after pancreaticoduodenectomy in patients with soft pancreas. 149
Impact of structured report on the quality of preoperative CT staging of pancreatic ductal adenocarcinoma: assessment of intra- and inter-reader variability 149
Arterially enhancing liver lesions: significance of sustained enhancement on hepatic venous and delayed phase with magnetic resonance imaging. 146
Three-dimensional contrast-enhanced ultrasound versus conventional two dimensional contrast-enhanced ultrasound in the evaluation of therapeutic response of hepatocellular carcinoma after local therapies. 146
Imaging findings of hepatic focal nodular hyperplasia in men and women: are they really different? 146
Imaging approach for evaluation of focal liver lesions 145
Hepatocellular carcinoma (HCC) with indeterminate findings at initial CT or MRI: Does imaging follow-up allow detection of conclusive imaging findings before significant tumor growth? 145
The abnormal hepatic morphology: not always cirrhosis 143
Intraindividual comparison of hepatic venous phase and delayed phase for the detection of washout contrast-enhancement pattern of HCC on MDCT of the liver. 141
The Evolving Scenario in the Assessment of Radiological Response for Hepatocellular Carcinoma in the Era of Immunotherapy: Strengths and Weaknesses of Surrogate Endpoints 140
Long-term evolution of LI-RADS observations in HCV-related cirrhosis treated with direct-acting antivirals 138
Benign focal lesions 137
Morphologic changes of the liver: how to recognize and analyze at CT and MRI 137
CT and MR imaging evaluation of hepatic adenoma. 134
UTILITÀ DELLA TC NELLA DIAGNOSI DELLA FISTOLA PANCREATICA DOPO DUODENOCEFALOPANCREASECTOMIA IN PAZIENTI CON SOFT PANCREAS 131
A Multicenter Assessment of Interreader Reliability of LI-RADS Version 2018 for MRI and CT 130
Hepatocellular and fibrolamellar carcinoma 130
Focal liver lesions in patients with cavernous transformation of the portal vein: diagnosis and MR features. 130
Congenital hepatic fibrosis: CT findings in 18 adults. 129
Hepatic Sinusoidal Dilatation: A Review of Causes With Imaging-Pathologic Correlation 129
Hepatocellular carcinoma in cirrhotic patients at MDCT: hepatic venous phase versus delayed phase for the detection of tumour washout 128
Radiomics Analysis on Gadoxetate Disodium-Enhanced MRI Predicts Response to Transarterial Embolization in Patients with HCC 126
Cavernous hemangioma associated with other hepatic masses at CT and MRI 126
Advances in liver US, CT, and MRI: moving toward the future 125
Hepatocellular carcinoma presenting at contrast-enhanced multi-detector-row computed tomography or gadolinium-enhanced magnetic resonance imaging as a small (2 cm), indeterminate nodule: growth rate and optimal interval time for imaging follow-up. 125
Uncommon evolutions and complications of common benign liver lesions 124
Growth rate of small (≤2 cm) HCC in cirrhotic patient: determining optimal screening interval with serial CT or MRI. 122
Abdominal Hernias 122
Benign liver lesions: Cysts and Cystic-Like Lesions. 120
Hyperintense nodule-in-nodule on hepatobiliary phase arising within hypovascular hypointense nodule: Outcome and rate of hypervascular transformation 120
Totale 18.125
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.924
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.924
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021160 0 0 0 0 0 0 0 0 0 0 0 160
2021/20221.427 79 298 38 46 50 86 60 62 219 171 61 257
2022/20231.994 213 315 44 177 257 289 104 178 239 20 113 45
2023/2024846 39 132 41 85 71 180 90 37 22 35 19 95
2024/20252.832 75 120 293 209 98 117 227 222 224 297 295 655
2025/20268.666 548 218 498 611 790 1.311 1.263 1.015 767 1.248 332 65
Totale 23.429